|Bid||49.75 x 800|
|Ask||49.82 x 1400|
|Day's range||49.53 - 50.90|
|52-week range||49.35 - 127.20|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||9.04|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
DENVER, September 21, 2021--Shuamn, Glenn & Stecker investigates Emergent BioSolutions, Inc. (NYSE: EBS).
LOS ANGELES, Jun 20, 2021--DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc.
LOS ANGELES, Jun 19, 2021--MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc.